.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent research identifies a critical pathway involving NINJ2 and Colitis Healing. Activation-induced cytidine deaminase (AID), usually associated with antibody diversity in B cells, also plays a pivotal role in the gut. Scientists found that AID is significantly expressed in colonic epithelial cells (CECs) during active inflammation. This discovery sheds light on how the body manages mucosal repair and inflammation in conditions like ulcerative colitis.
The study utilized a colorectal cancer cell line (DLD-1) to observe the effects of AID overexpression. Researchers identified over 600 genes induced by AID, including those within the mTOR and MAPK signaling pathways. Specifically, the expression of the NINJ2 gene increased fivefold. AID binds directly to the NINJ2 promoter and enhancer regions. Subsequently, it induces DNA demethylation, which triggers transcriptional upregulation. This molecular switch is essential for maintaining the integrity of the colonic lining.
Furthermore, the physiological impact of this pathway was tested in mouse models. AID-knockout mice showed a significant delay in recovery from induced colitis compared to wild-type mice. Because NINJ2 expression was lower in these knockout mice, the wound healing process stalled. Therefore, the researchers concluded that inflammation-driven AID upregulation is a protective response. It facilitates tissue repair by boosting NINJ2 transcription through epigenetic modifications. This process ultimately promotes faster resolution of intestinal damage.
NINJ2 is a cell surface adhesion protein. In the colon, it promotes tissue repair and wound healing after inflammatory injury by facilitating epithelial cell interactions.
AID binds to specific gene regions and promotes DNA demethylation. This epigenetic change allows genes like NINJ2 to be expressed more easily during periods of cellular stress or inflammation.
Understanding how the body naturally heals colonic wounds could lead to new therapies. Boosting the AID-NINJ2 pathway might accelerate recovery for patients suffering from inflammatory bowel disease.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A new study reveals that Activation-induced cytidine deaminase (AID) enhances the expression of the NINJ2 gene through DNA demethylation. This pathway is crucial for colonic wound healing and recovery from colitis, offering potential new avenues for treating inflammatory bowel disease and colorectal health.
2 months ago
A New York City initiative successfully distributed over 48,000 COVID-19 oral antiviral prescriptions through rapid home delivery in 2022. With 92% delivered within 24 hours, the program safeguarded vulnerable and elderly populations, establishing an equitable framework for emergency drug distribution.
Today
A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today
Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today
Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday
Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today
